Additional file 3: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Therapeutic drug monitoring of voriconazole.

Bruggemann, R.J.M.
Donnelly, J.P.
Aarnoutse, R.E.
Warris, A.
Blijlevens, N.M.A.
Mouton, J.W.
Verweij, P.E.
Burger, D.M.

January 2008

Contains fulltext : 70639.pdf (publisher's version ) (Closed access)Voriconazole i...

Additional file 2: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S2. Distributions used in the probabilistic sensitivity analysis. Table summarising the probab...

Additional file 5 of Microbiota of the indoor environment: a meta-analysis

Rachel Adams (88955)
Ashley Bateman (3269067)
Holly Bik (199228)
James Meadow (2923056)

October 2015

Text S1. Fungal analysis. Description of the analysis steps for the fungal studies and basic finding...

Additional file 4: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Yuanming Xing (4722273)
Lu Chen (75170)
Yan Feng (128912)
Yan Zhou (6523)
Yajing Zhai (4329064)
Jun Lu (36049)

December 2017

The funnel plots for the tolerability, neurotoxicity, visual toxicity, hepatotoxicity, and nephrotox...

Additional file 1: of Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis

Lu Chen (75170)
Yan Wang (15435)
Tao Zhang (43681)
Ying Li (38224)
Ti Meng (5049200)
Leichao Liu (5049197)
Ruifang Hao (5049194)
Yalin Dong (3592028)

April 2018

Table S1. Summary of sensitive analysis for prophylaxis efficacy. Figure S1. Source of bias in two r...

Additional file 1: of Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis

Ken Chen (61463)
Qi Wang (22418)
Roy Pleasants (3760012)
Long Ge (511458)
Wei Liu (20030)
Kangning Peng (3760009)
Suodi Zhai (3328581)

February 2017

Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...

Additional file 3: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S3. Parameters tested in deterministic sensitivity analysis. Table summarising the parameters ...

Additional file 1: of Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Table S1. Characteristics of the studies included in the meta-analysis. Table S2. Quality of assessm...

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

February 2011

Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia Un...

Additional file 3: of Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis

Qing An (5832917)
Zhihao Liu (419349)

January 2019

Figure S1. Risk of bias summary for each risk of bias item for each included study. (PDF 538 kb

Additional file 1: of Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients

Houdaii El-Houssaini (6237881)
Omnia Elnabawy (6237884)
Hebatallah Nasser (6237887)
Walid Elkhatib (6237890)

January 2019

Minimum inhibitory concentration values amongst C. albicans isolates for each antifungal agent. Desc...

Additional file 2: of Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Forest plots of odds ratios for second outcomes (see in Figure S1-S8). (DOCX 11351 kb

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Kullberg, B.J.
Sobel, J.D.
Ruhnke, M.
Pappas, P.G.
Viscoli, C.
Rex, J.H.
Cleary, J.D.
Rubinstein, E.
Church, L.W.
Brown, J.M.
Schlamm, H.T.
Oborska, I.T.
Hilton, F.
Hodges, M.R.

January 2005

Contains fulltext : 48229.pdf (publisher's version ) (Closed access)BACKGROUND: Vo...

Additional file 1: of Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials

Yannick Wirz (5636450)
Marc Meier (4775451)
Lila Bouadma (147823)
Charles Luyt (5636453)
Michel Wolff (147901)
Jean Chastre (5636456)
Florence Tubach (77841)
Stefan Schroeder (5512685)
Vandack Nobre (4175917)
Djillali Annane (3732)
Konrad Reinhart (51097)
Pierre Damas (20576)
Maarten Nijsten (3477845)
Arezoo Shajiei (5636459)
Dylan deLange (5636462)
Rodrigo Deliberato (5636465)
Carolina Oliveira (5636468)
Yahya Shehabi (51763)
Jos van Oers (5636471)
Albertus Beishuizen (70118)
Armand Girbes (5594855)
Evelien de Jong (5512688)
Beat Mueller (300968)
Philipp Schuetz (33688)

August 2018

Figure S1. Assessment of risk of bias in included trials. Figure S2. Forrest plot based on aggregate...

Additional file 1: of The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis

Libing Jiang (669302)
Yi Sheng (87897)
Xia Feng (179439)
Jing Wu (54032)

March 2019

Table S1. Study search strategy. Table S2. Information on excluded studies. Table S3. List of Ongoin...

Therapeutic drug monitoring of voriconazole.

Bruggemann, R.J.M.
Donnelly, J.P.
Aarnoutse, R.E.
Warris, A.
Blijlevens, N.M.A.
Mouton, J.W.
Verweij, P.E.
Burger, D.M.

January 2008

Contains fulltext : 70639.pdf (publisher's version ) (Closed access)Voriconazole i...

Additional file 2: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S2. Distributions used in the probabilistic sensitivity analysis. Table summarising the probab...

Additional file 5 of Microbiota of the indoor environment: a meta-analysis

Rachel Adams (88955)
Ashley Bateman (3269067)
Holly Bik (199228)
James Meadow (2923056)

October 2015

Text S1. Fungal analysis. Description of the analysis steps for the fungal studies and basic finding...

Additional file 4: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Yuanming Xing (4722273)
Lu Chen (75170)
Yan Feng (128912)
Yan Zhou (6523)
Yajing Zhai (4329064)
Jun Lu (36049)

December 2017

The funnel plots for the tolerability, neurotoxicity, visual toxicity, hepatotoxicity, and nephrotox...

Additional file 1: of Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis

Lu Chen (75170)
Yan Wang (15435)
Tao Zhang (43681)
Ying Li (38224)
Ti Meng (5049200)
Leichao Liu (5049197)
Ruifang Hao (5049194)
Yalin Dong (3592028)

April 2018

Table S1. Summary of sensitive analysis for prophylaxis efficacy. Figure S1. Source of bias in two r...

Additional file 1: of Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis

Ken Chen (61463)
Qi Wang (22418)
Roy Pleasants (3760012)
Long Ge (511458)
Wei Liu (20030)
Kangning Peng (3760009)
Suodi Zhai (3328581)

February 2017

Table S1. Sample search strategy for MEDLINE. Table S2. The reason for excluding studies. Table S3. ...

Additional file 3: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S3. Parameters tested in deterministic sensitivity analysis. Table summarising the parameters ...

Additional file 1: of Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Table S1. Characteristics of the studies included in the meta-analysis. Table S2. Quality of assessm...

Update on the optimal use of voriconazole for invasive fungal infections

Asma Lat George R Thompson III

February 2011

Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia Un...

Additional file 3: of Comparative efficacy and safety of combination therapies for advanced melanoma: a network meta-analysis

Qing An (5832917)
Zhihao Liu (419349)

January 2019

Figure S1. Risk of bias summary for each risk of bias item for each included study. (PDF 538 kb

Additional file 1: of Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients

Houdaii El-Houssaini (6237881)
Omnia Elnabawy (6237884)
Hebatallah Nasser (6237887)
Walid Elkhatib (6237890)

January 2019

Minimum inhibitory concentration values amongst C. albicans isolates for each antifungal agent. Desc...

Additional file 2: of Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis

Changcheng Shi (837948)
Yubo Xiao (5845658)
Qi Zhang (28502)
Qingyu Li (417678)
Fei Wang (19534)
Jing Wu (54032)
Nengming Lin (837949)

October 2018

Forest plots of odds ratios for second outcomes (see in Figure S1-S8). (DOCX 11351 kb

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Kullberg, B.J.
Sobel, J.D.
Ruhnke, M.
Pappas, P.G.
Viscoli, C.
Rex, J.H.
Cleary, J.D.
Rubinstein, E.
Church, L.W.
Brown, J.M.
Schlamm, H.T.
Oborska, I.T.
Hilton, F.
Hodges, M.R.

January 2005

Contains fulltext : 48229.pdf (publisher's version ) (Closed access)BACKGROUND: Vo...

Additional file 1: of Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials

Yannick Wirz (5636450)
Marc Meier (4775451)
Lila Bouadma (147823)
Charles Luyt (5636453)
Michel Wolff (147901)
Jean Chastre (5636456)
Florence Tubach (77841)
Stefan Schroeder (5512685)
Vandack Nobre (4175917)
Djillali Annane (3732)
Konrad Reinhart (51097)
Pierre Damas (20576)
Maarten Nijsten (3477845)
Arezoo Shajiei (5636459)
Dylan deLange (5636462)
Rodrigo Deliberato (5636465)
Carolina Oliveira (5636468)
Yahya Shehabi (51763)
Jos van Oers (5636471)
Albertus Beishuizen (70118)
Armand Girbes (5594855)
Evelien de Jong (5512688)
Beat Mueller (300968)
Philipp Schuetz (33688)

August 2018

Figure S1. Assessment of risk of bias in included trials. Figure S2. Forrest plot based on aggregate...

Additional file 1: of The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis

Libing Jiang (669302)
Yi Sheng (87897)
Xia Feng (179439)
Jing Wu (54032)

March 2019

Table S1. Study search strategy. Table S2. Information on excluded studies. Table S3. List of Ongoin...

Therapeutic drug monitoring of voriconazole.

Bruggemann, R.J.M.
Donnelly, J.P.
Aarnoutse, R.E.
Warris, A.
Blijlevens, N.M.A.
Mouton, J.W.
Verweij, P.E.
Burger, D.M.

January 2008

Contains fulltext : 70639.pdf (publisher's version ) (Closed access)Voriconazole i...

Additional file 2: of Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros (6323558)
Daniel Kuessner (5640473)
Jan Posthumus (5640476)
Emma Bagshaw (3347507)
Jan SjĂślin (6323564)

February 2019

Table S2. Distributions used in the probabilistic sensitivity analysis. Table summarising the probab...

Additional file 5 of Microbiota of the indoor environment: a meta-analysis

Rachel Adams (88955)
Ashley Bateman (3269067)
Holly Bik (199228)
James Meadow (2923056)

October 2015

Text S1. Fungal analysis. Description of the analysis steps for the fungal studies and basic finding...

Additional file 3: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Abstract

Extracted data

Additional file 3: of Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections

Abstract

Extracted data

Related items

Related items